EUVIMEDEUVIMED entdecken
Crossref

Efficacy of low-dose olanzapine in preventing chemotherapy-induced nausea and vomiting in patients with steroid intolerance

Megha Manhas, Amba Prasad Dubey, DrNB Rangaram Kumar Choudhary, Pankaj Deep Rana, Rahul Rai

Asian Journal of Oncology · 12.05.2026 · 12 · 12

DOI: 10.25259/asjo_80_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Oncology, online erschienen am 12.05.2026. Verfasst von Megha Manhas und 4 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the efficacy and safety of low-dose olanzapine in preventing chemotherapy-induced nausea and vomiting (CINV) in patients intolerant to corticosteroids. Material and Methods: Fifty patients receiving moderately or highly emetogenic chemotherapy were included. All patients received a standard antiemetic regimen comprising a 5-HT3 receptor antagonist, an NK1 receptor antagonist (for highly emetogenic chemotherapy), and low-dose olanzapine (2.5 mg daily for three to five days). Patients recorded episodes of nausea, vomiting, need for rescue therapy, and adverse effects.

Results

CINV was observed in 6% of patients, and vomiting occurred in 2%. Sedation (12%), weight gain (4%), and increased appetite (32%) were the most commonly reported side effects. No severe toxicities were observed, and treatment adherence was high.

Conclusion

Low-dose olanzapine is an effective and well-tolerated option for CINV prevention in patients unable to tolerate corticosteroids, offering a favorable safety profile.

Zitieren

APA

Manhas, M., Dubey, A. P., Choudhary, D. R. K., Rana, P. D., & Rai, R. (2026). Efficacy of low-dose olanzapine in preventing chemotherapy-induced nausea and vomiting in patients with steroid intolerance. Asian Journal of Oncology, 12, 12. https://doi.org/10.25259/asjo_80_2025

Vancouver

Manhas M, Dubey AP, Choudhary DRK, Rana PD, Rai R. Efficacy of low-dose olanzapine in preventing chemotherapy-induced nausea and vomiting in patients with steroid intolerance. Asian Journal of Oncology. 2026;12:12. doi:10.25259/asjo_80_2025

BibTeX
@article{Manhas2026,
  author = {Manhas, Megha and Dubey, Amba Prasad and Choudhary, DrNB Rangaram Kumar and Rana, Pankaj Deep and Rai, Rahul},
  title = {Efficacy of low-dose olanzapine in preventing chemotherapy-induced nausea and vomiting in patients with steroid intolerance},
  journal = {Asian Journal of Oncology},
  year = {2026},
  volume = {12},
  pages = {12},
  doi = {10.25259/asjo_80_2025}
}
Kostenlos starten →